←back to thread

275 points swores | 1 comments | | HN request time: 0.354s | source
Show context
FredPret ◴[] No.40173118[source]
Drugs may be overpriced.

There is probably some bloat in drug development. But then again, maybe not. I'm not an expert.

What I do know is that drugs have gotten dramatically better in the short amount of time I've been alive.

The other thing we all know is that the source of this article, The Guardian and their friends, have a shitlist of industries and institutions it loves to hate.

Ask yourself: will they ever write a positive article about a defense contractor, a bank, big pharma, a US billionaire, or a landlord, even if said entity walks on water and then saves a million babies and the penguins and the world?

replies(4): >>40173169 #>>40173184 #>>40173519 #>>40173529 #
1. kwhitefoot ◴[] No.40173529[source]
The article is mostly not about drug development as a whole, merely the cost of trials. All that is being asked is that the cost of trials be public information.